Healthcare -
Drug Manufacturers - Specialty & Generic - NYSE - US
$ 8.26
-0.602 %
$ 3.77 B
Market Cap
-9.49
P/E
Price Target
Average
21.07%
Revenue Forecast
Estimate
27.93%
EBIT
Estimate
--47.51%
Net Income
Estimate
100.00%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Amneal Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for AMRX of $10 , with forecasts ranging from
a
low of
$8 to a high of $12 .
AMRX Lowest Price Target
Wall Street Target
8 USD
-3.15%
AMRX Average Price Target
Wall Street Target
10 USD
21.07%
AMRX Highest Price Target
Wall Street Target
12 USD
45.28%
REVENUE FORECAST
Revenue Forecast Chart AMRX
EBIT FORECAST
EBIT Forecast Chart AMRX
NET INCOME FORECAST
Net Income Chart AMRX